Filing Flows › Elutia (ELUT) › Recalls, complaints & regulation
Elutia (ELUT): clinical trials
Elutia (ELUT) beyond its filings: 1 active clinical trial.
Elutia's latest quarter
Elutia, Q2 2026: revenue $2.4M (-12% year over year), operating margin -327.9%, net loss $7.6M, operating cash flow −$8.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Elutia have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.